PlainRecalls
FDA Drug Moderate Class II Terminated

Mesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories, FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054, NDC 0591-2245-22.

Reported: November 18, 2020 Initiated: October 28, 2020 #D-0069-2021

Product Description

Mesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories, FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054, NDC 0591-2245-22.

Reason for Recall

Failed Dissolution Specifications: Out-of-specification dissolution results were obtained during stability testing.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
133,829 bottles
Distribution
Nationwide in the U.S. and PR
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Mesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories, FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054, NDC 0591-2245-22.. Recalled by Teva Pharmaceuticals USA. Units affected: 133,829 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Out-of-specification dissolution results were obtained during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 18, 2020. Severity: Moderate. Recall number: D-0069-2021.